Trial intelligence / Profile preview

Topical Verrumal for common warts in organ transplant recipients (double-blind, randomized, placebo-controlled)

2005-001593-26Phase 4Completed

Sponsor
Hermal
Start
Jun 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in common wart comparing Verrumal active treatment with Placebo control (2 arms). Primary endpoint: Clinical response to treatment. Started Jun 2005; status: completed.

02

Drugs

fluorouracil + salicylic acid
03

Conditions

common wart

Beyond the preview

Go deeper on 2005-001593-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-001593-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call